Cargando…
Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
BACKGROUND: To investigate outcomes and morbidity of patients undergoing secondary cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer. MATERIALS AND METHODS: Between April 2014 and January 2019, a total of 51 recurrent ovarian cancer patient...
Autores principales: | Chen, Wei-Chun, Huang, Huei-Jean, Yang, Lan-Yan, Pan, Yu-Bin, Huang, Kuan-Gen, Lin, Cheng-Tao, Chen, Min-Yu, Tang, Yun-Hsin, Chang, Ting-Chang, Lai, Chyong-Huey, Chou, Hung-Hsueh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661499/ https://www.ncbi.nlm.nih.gov/pubmed/34656802 http://dx.doi.org/10.1016/j.bj.2021.10.003 |
Ejemplares similares
-
The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021) -
Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy
por: Chen, Wei-Chun, et al.
Publicado: (2023) -
Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
por: Chen, Wei-Chun, et al.
Publicado: (2022) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020) -
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018)